AXTI AXT INC
Semiconductors & Related Devices · Nasdaq · SEC CIK 1051627 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY89.1%
TTM net income YoY239.0%
TTM EPS YoY192.5%
Revenue 3-yr CAGR27.7%
Net income 3-yr CAGR—
Margins
Gross margin44.0%
Operating margin19.6%
Net margin18.5%
FCF margin46.5%
EBITDA margin25.3%
Returns
ROE5.8%
ROA4.1%
ROIC (approx.)8.3%
Asset turnover0.22x
Leverage & solvency
Liabilities / assets19.3%
Debt / equity0.10x
Current ratio3.80x
Interest coverage—
Cash quality & payout
Operating cash flow / net income3.32x
Accruals ratio-9.5%
Payout ratio—
Capex / revenue15.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $88.33M | $99.36M |
| Cost of revenue | $77.08M | $75.53M |
| Gross profit | $11.24M | $23.84M |
| R&D expense | $9.05M | $14.54M |
| SG&A expense | $24.17M | $24.10M |
| Operating income | -$21.98M | -$14.80M |
| Interest expense | $1.26M | $1.34M |
| Pretax income | -$21.54M | -$10.66M |
| Income tax | $1.66M | $1.13M |
| Net income | -$21.26M | -$11.62M |
| EBITDA | -$12.87M | -$5.82M |
| EPS (basic) | -0.49 | -0.27 |
| EPS (diluted) | -0.49 | -0.27 |
| Weighted avg. shares (diluted) | 43.93M | 43.15M |
| Balance sheet | ||
| Cash & equivalents | $120.27M | $22.83M |
| Short-term investments | $0 | — |
| Receivables | $26.85M | $25.64M |
| Inventory | $81.65M | $85.08M |
| Current assets | $246.56M | $158.27M |
| PP&E, net | $161.86M | $159.72M |
| Total assets | $433.75M | $339.31M |
| Current liabilities | $90.54M | $74.18M |
| Short-term debt | $62.80M | $47.26M |
| Total liabilities | $99.12M | $84.41M |
| Shareholders' equity | $273.29M | $192.77M |
| Shares outstanding | 55.24M | 45.36M |
| Cash flow statement | ||
| Operating cash flow | -$12.78M | -$12.11M |
| Capital expenditure | $6.00M | $5.77M |
| Free cash flow | -$18.78M | -$17.88M |
| Investing cash flow | -$6.83M | -$4.45M |
| Financing cash flow | $107.09M | -$536,000 |
| Depreciation & amortization | $9.11M | $8.98M |
| Stock-based compensation | $3.29M | $3.10M |
Free plan shows the latest 2 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.